Robot-assisted total pelvic exenteration for rectal cancer after neoadjuvant chemoradiotherapy: a case report

Robot-assisted total pelvic exenteration for rectal cancer after neoadjuvant chemoradiotherapy: a case report

Blog Article

Abstract Background There are numerous indications for minimally invasive surgery.However, the laparoscopic approach for extended pelvic surgery is currently provided by only a few institutions specializing in cancer treatment, primarily because of technical difficulties that arise in cases involving a narrow pelvis and rigid forceps.We report a case of robot-assisted total pelvic exenteration for rectal cancer involving the prostate.We assessed the feasibility of robot-assisted total pelvic exenteration and compared the short-term outcomes of other conventional airpods pro houston and minimally invasive approaches.

Case presentation A 67-year-old man was referred to our hospital after positive fecal blood test results.The initial diagnosis was clinical T4bN2aM0, Stage IIIC rectal cancer involving the prostate.The patient underwent neoadjuvant chemoradiotherapy.Consequently, robot-assisted total pelvic exenteration surface awaken protein mousse with an ileal conduit and end colostomy creation were performed.

The total operative duration was 9 h and 20 min.The durations of robot console usage by the colorectal and urological teams were 2 h 9 min and 2 h 23 min, respectively.The patient was discharged on postoperative day 21.The pathological diagnosis was T4b (prostate) N0M0, Stage IIC.

The resection margin was 2.5 mm.During reassessment at 2 years after resection, no evidence of recurrence was observed.Conclusions Robot-assisted total pelvic exenteration was performed for a patient with advanced rectal cancer without serious complications.

Robot-assisted total pelvic exenteration may provide the advantages of minimally invasive surgery, particularly in the enclosed space of the pelvis.